A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors

NCT07268040 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Solid Tumors

Interventions

DRUG: SHR-7787 Injection
DRUG: SHR-1316 Injection
DRUG: SHR-4849 Injection
DRUG: Etoposide injection
DRUG: Carboplatin injection
DRUG: Cisplatin injection
DRUG: BP102 Injection

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.